Bloomberg News (11/2, Fisk, Hawkins, 1M) reports that “Johnson & Johnson (JNJ) settled lawsuits with about 845 plaintiffs who claimed” the pharmaceutical company “didn’t properly warn of the risks of tendon damage from its antibiotic Levaquin [levofloxacin].” The article said that “the settlements were disclosed in an Oct. 30 filing in federal court in Minneapolis, where a judge is overseeing about 1,900 Levaquin lawsuits.” Bloomberg News adds that “according to the filing, Johnson & Johnson faces more than 3,400 state and federal lawsuits alleging tendon injuries from the drug, including about 1,500 cases in New Jersey state court.”